Regentis Biomaterials (RGNT) Preferred Stock Liabilities (2024)
Regentis Biomaterials (RGNT) posted quarterly Preferred Stock Liabilities of $35.1 million for Q4 2024.
Regentis Biomaterials (RGNT) Preferred Stock Liabilities (2024) Analysis & Trends
Regentis Biomaterials (RGNT) has reported Preferred Stock Liabilities for 1 consecutive years, with $35.1 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Preferred Stock Liabilities changed N/A year-over-year to $35.1 million; the TTM figure through Dec 2024 stood at $35.1 million (changed N/A YoY), while the FY2024 annual figure was $35.1 million, changed N/A from the prior year.
- Preferred Stock Liabilities steadied at $35.1 million in Q4 2024 per RGNT's latest filing.
- Across five years, Preferred Stock Liabilities topped out at $35.1 million in Q4 2024 and bottomed at $35.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Regentis Biomaterials | 1.21 Mn | -6.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 35.10 Mn |